Related Experiment Video
Updated: May 15, 2026

Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures
Published on: December 27, 2024
ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis
L P Vaites1, Z Lian1, E K Lee1
11] The Leonard and Madlyn Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, PA, USA [2] Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA, USA.
Abstract:
Cyclin D1 deregulation is implicated in the genesis of multiple human cancers. Importantly, nuclear cyclin D1 retention during S-phase promotes DNA re-replication and subsequent genomic instability, providing a direct correlation between aberrant cyclin D1/CDK4 activity, transcriptional regulation and double strand DNA break (DSB) induction. Together, these molecular events catalyze the genomic instability necessary for neoplastic transformation. Given that replication-associated DNA damage is central to cyclin D1-driven neoplasia, inactivation of critical checkpoint mediators should augment cyclin D1-dependent tumorigenesis in vivo. To interrogate potential synergy between constitutively nuclear cyclin D1 expression and impaired DSB-induced checkpoint integrity, Ataxia Telangiectasia Mutated (ATM)-deficient mice harboring the Eμ-D1T286A transgene were generated and evaluated for tumor onset. Eμ-D1T286A/ATM-/- mice exhibit dramatically accelerated incidence of both B- and T-cell lymphomas relative to Eμ-D1T286A or ATM-/- control cohorts. Lymphomas exhibit clonal chromosomal alterations distinct from ATM-/- mice, which typically acquire translocations involving the Tcrα/δ locus during V(D)J recombination, and instead harbor alterations at the c-Myc locus. Collectively, these findings reveal an intricate relationship wherein nuclear cyclin D1/CDK4 drives genomic instability in the absence of ATM function and clonal selection of cells harboring alterations within the murine c-Myc locus, ultimately facilitating transformation and tumor formation.
Insights
Nuclear cyclin D1 retention drives cancer by causing DNA damage and genomic instability. Inactivating ATM in mice accelerates lymphoma development, highlighting a link between DNA repair, cyclin D1, and cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cyclin D1 deregulation is a key factor in human cancer development.
- Nuclear cyclin D1 retention during S-phase causes DNA re-replication and genomic instability.
- This instability is linked to aberrant cyclin D1/CDK4 activity, transcriptional dysregulation, and DNA double-strand break (DSB) induction.
Purpose of the Study:
- To investigate the synergistic effects of constitutively nuclear cyclin D1 expression and impaired DNA double-strand break (DSB) checkpoint integrity.
- To determine if inactivating critical checkpoint mediators augments cyclin D1-dependent tumorigenesis in vivo.
Main Methods:
- Generated and evaluated Ataxia Telangiectasia Mutated (ATM)-deficient mice harboring the Eμ-D1T286A transgene for tumor onset.
- Compared tumor incidence and chromosomal alterations in Eμ-D1T286A/ATM-/- mice with control cohorts (Eμ-D1T286A and ATM-/-).
Main Results:
- Mice with both Eμ-D1T286A transgene and ATM deficiency (Eμ-D1T286A/ATM-/-) showed significantly accelerated B- and T-cell lymphoma incidence.
- Lymphomas in these mice displayed distinct clonal chromosomal alterations, particularly at the c-Myc locus, unlike ATM-/- mice which typically showed Tcrα/δ locus translocations.
- Nuclear cyclin D1/CDK4 activity drives genomic instability in the absence of ATM function, leading to c-Myc locus alterations and tumor formation.
Conclusions:
- Nuclear cyclin D1/CDK4 activity is a critical driver of genomic instability when ATM function is compromised.
- This interplay facilitates the clonal selection of cells with c-Myc locus alterations, promoting neoplastic transformation and tumor development.
- Findings reveal a complex relationship between cyclin D1, ATM, and c-Myc in cancer pathogenesis.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Inhibition of Cdk Activity
Anaphase Promoting Complex

